Delivery Order HHSN272201100005I-HHSN27200005

Award Date 8/26/15
Potential Completion Date 9/29/16
Potential Value $59K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the prime contractor Bioqual, Inc. The contract, valued at $31,452, is a Delivery Order under the In Vitro Antimicrobial Assessments 2011-2018 indefinite-delivery/indefinite-quantity (IDIQ) master contract. The contract is for a "Comprehensive Panel for Viruses" and does not have a set-aside designation. Bioqual, Inc. is an...
This is a Firm Fixed Price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc. under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The $96,868.00 order is for PCMID Task Order A27 to support pre-clinical models of infectious diseases research. Bioqual, a for-profit organization, is a prime contractor and subcontractor that provides animal...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc. as the prime contractor. The $12,103.00 firm fixed-price delivery order is part of the larger In Vitro Antimicrobial Assessments 2011-2018 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. The contract is for in vitro assessment services related to NIAID's biomedical research programs. No set-aside was used. Bioqual, Inc. is a fully...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bioqual, Inc. The contract has a ceiling value of $21,695.00 and was awarded on September 17, 2012 as a Firm Fixed Price Delivery Order under the larger "In Vitro Antimicrobial Assessments 2011-2018" indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The contract is for "OTHER FUNCTIONS:IN VITRO...
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Bioqual, Inc. for the housing and maintenance of laboratory animals for NIAID's Vaccine Research Center (VRC). The contract has a ceiling value of $5,203,514.91 and a period of performance through December 3, 2020. Bioqual, Inc. is a for-profit company that provides animal research support...
This is a $1,887,979.00 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a for-profit biomedical research services company based in Rockville, Maryland. The contract is for "CONDUCT STUDY P215" under the Simian Vaccine Evaluation Units (SVEUS) major program. This delivery order is not associated with a set-aside program. Bioqual has been awarded multiple NIAID contracts, including a...
This is a cost-plus-fixed-fee delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Bioqual, Inc., a for-profit organization, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The order, valued at $2,699,500.00, is for task work related to preclinical models of infectious diseases from September 24, 2018 through September 30, 2020....
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a for-profit organization, to conduct a study called "CONDUCT STUDY P221." The contract has a ceiling value of $1,999,460.00 and is a delivery order under the Simian Vaccine Evaluation Units (SVEU) indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle held by NIAID. The contract has an ultimate completion date of August 31, 2025...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bioqual, Inc., a for-profit biomedical research services company located in Rockville, Maryland. The contract is for the housing and maintenance of non-human primates for NIAID's Vaccine Research Center (VRC), with a total ceiling value of $2,438,569.73 and a period of performance through July 2, 2024. The contract was awarded on August 8, 2019 and is a firm...
This is a Firm Fixed Price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) to Bioqual, Inc., a for-profit company that provides animal research support services. The contract, valued at $125,064.00, is for TASK A26 under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ contract, which allows for task orders related to primate vaccine studies, care, and housing....

This is a firm-fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Bioqual, Inc., a for-profit organization, for a "COMPREHENSIVE PANEL FOR VIRUSES" with a ceiling value of $58,883.00. The contract was awarded on August 26, 2015, with an ultimate completion date of September 29, 2016. This delivery order is associated with the larger "In Vitro Antimicrobial Assessments 2011-2018" indefinite-delivery/indefinite-quantity (IDIQ) contract held by NIAID. Bioqual has received multiple prime contract and subcontract awards from NIAID and other federal agencies for animal research, laboratory analysis, and housing and care services related to infectious disease studies.

Generated 11/24/24, 9:38 AM